ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1622

ASAS Consensus on Spanish Nomenclature for Spondyloarthritis

Victoria Navarro-Compán1, Teresa Oton-Sanchez2, Estibaliz Loza3, Raquel Almodóvar González4, Rafael Ariza5, Wilson Bautista-Molano6, Rubén Burgos-Vargas7, Eduardo Collantes Estevez8, Eugenio De Miguel9, Carlos M Gonzalez10, Jordi Gratacos-Masmitja11, Sebastián Ibáñez12, Xavier Juanola13, José A. Maldonado-Cocco14, Anna Molto15, Juan D. Mulero16, Cesar Pacheco-Tena17, Cesar Ramos-Remus18, Jesus Sanz19, Rafael Valle-Oñate20, Pedro Zarco21 and Helena Marzo-Ortega22, 1Immuno-Rheumatology research group, IdiPaz. La Paz University Hospital, Madrid, Spain, 2InMusc. Instituto de Salud Músculo-Esquelética, Madrid, Spain, 3INMUSC, Instituto de Salud Musculoesquelética (InMusc), Madrid, Spain, 4Rheumatology, Hospital Universitario Fundación Alcorcón. Madrid. Spain, Madrid, Spain, 5Rheumatology, Hospital Universitario Virgen Macarena, Sevilla, Spain, 6Hospital Militar, Bogotá, Colombia, 7Department of Rheumatology, Hospital General de México "Dr. Eduardo Liceaga", Mexico City, Mexico, 8IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 9Rheumatology, University Hospital La Paz, IdiPaz, Madrid, Spain, 10Servicio de Reumatología, Hospital General Universitario Gregorio Marañón, Madrid, Spain, 11Rheumatology, Hospital Parc Taulí, Sabadell - Barcelona, Spain, 12Rheumatology Department, Clínica Alemana de Santiago, Santiago, Chile, 13Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, 14Buenos Aires University, Consulting Professor of Rheumatology, Buenos Aires University. Argentina, Buenos Aires, Argentina, 15Hôpital Cochin, Department of Rheumatology, Paris Descartes University, Paris, France, 16Hospital Puerta de Hierro, Majadahonda, Madrid, Spain, 17Universidad Autónoma de Chihuahua, Hospital Christus Muguerza del Parque, Chihuahua, Mexico, 18Universidad Autonoma de Guadalajara, Zapopan, Mexico, 19Rheumatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain, 20Unidad de Reumatologia, Hospital Militar, Bogota, Colombia, 21H Fundación Alcorcón, Alcorcón, Spain, 22NIHR LBRC, LTHT and LIRMM, UoL, Leeds, United Kingdom

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Spondylarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Clinical/Epidemiology Studies

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: In the last three decades, major advances in the spondyloarthritis (SpA) field have been achieved leading to new terminology. Whilst this terminology is well established in English, there is concern about the disparity of translated words and acronyms in Spanish, which is used by more than 437 million people in 21 countries. Our aim was to develop a consensus to standardize the use of Spanish terms, abbreviations and acronyms in the field of Spondyloarthritis (SpA).

Methods: An international task force comprising all ASAS Spanish-speaking native members, the executive committee of GRESSER, two methodologists, two linguists from Real Academia Nacional de la Medicina Española (RANM) and two patients from CEADE was established. A literature review was performed to identify the conflicting terms/abbreviations/acronyms in SpA. This review examined written sources in Spanish including manuscripts, ICF and ICD, guidelines, recommendations and consensus. A nominal group meeting and three-round Delphi was followed. The recommendations from the RANM based on the Panhispanic dictionary were followed throughout the process.

Results: Consensus was reached for 46 terms, abbreviations or acronyms related to the field of SpA. A Spanish translation was accepted for 6 terms and 6 abbreviations to name or classify the disease, and for 6 terms and 4 abbreviations related to SpA (Table 1). In addition, it was agreed not to translate into Spanish 15 acronyms because these are very well established. However, when mentioning these, it was decided to recommend following this structure: type of acronym in Spanish and acronym and expanded form in English (Table 2). With regards to 7 terms or abbreviations attached to acronyms, it was agreed to translate only the expanded form and a translation was also selected for all of them.

Conclusion: Through this standarisation, it is expected to establish a common use of the Spanish nomenclature for SpA. The implementation of this consensus across the community will be of substantial benefit, avoiding misunderstandings and time-consuming procedures.

Table 1. Terms and abbreviations recommended by the group of experts.

#

English term (abbreviation)

Spanish term

Spanish abbreviation

1

Spondyloarthritis (SpA)

Espondiloartritis

EspA

2

Axial spondyloarthritis (axSpA)

Espondiloartritis axial

EspAax

3

Ankylosing spondylitis (AS), radiographic spondyloarthritis (r-SpA)

Espondilitis Anquilosante

EA

4

Non radiographic axial spondyloarthritis (nr-axSpA)

Espondiloartritis axial no radiografica

EspAax-nr

5

Peripheral spondyloarthritis (pSpA)

Espondiloartritis periferica

EspAp

6

Psoriatic arthritis (PsA)

Artritis psoriasica

APs

7

Inflammatory back pain (IBP)

Dolor lumbar inflamatorio

DLI

8

Magnetic resonance imaging  of the sacroiliac joints (MRI-SI)

Resonancia Magnética de articulaciones sacroiliacas

RM-SI

9

Bone marrow edema (BME)

Edema de medula osea

EMO

10

Modified New York criteria (mNY)

Criterios de Nueva York modificados

NYm

Table 2. Recommended structure to name acronyms and terms related to these acronyms.

2A

Acronyms

LoA

1

Grupo ASAS (Assessment in SpondyloArthritis International Society)

100%

2

Indice de actividad ASDAS (Ankylosing Spondylitis Disease Activity Score)

100%

3

Indice de actividad BASDAI (Bath Ankylosing Spondylitis Disease Activity Index)

100%

4

Indice de calidad de vida ASQoL (Ankylosing Spondylitis. Quality of Life)

100%

5

Indice de calidad de vida PsAQoL (Psoriatic Arthritis Quality of Life)

100%

6

Indice ecografico MASEI (Madrid Sonographic Enthesitis Index)

100%

7

Indice de entesitis MASES (Maastricht Ankylosing Spondylitis Enthesitis)

100%

8

Indice funcional BASFI (Bath Ankylosing Spondylitis Functional Index)

100%

9

Indice global BAS-G (Bath Ankylosing Spondylitis patient Global score)

94%

10

Indice metrologico BASMI (Bath Ankylosing Spondylitis Metrology Index)

94%

11

Indice de psoriasis PASI (Psoriasis Area and Severity Index)

100%

12

Indice radiografico BASRI (Bath Ankylosing Spondylitis Radiology Index

100%

13

Indice radiografico mSASSS (modified Stoke Ankylosing Spondylitis Spine Score)

100%

14

Indice radiografico PARS (Psoriatic Arthritis Ratingen Score)

100%

15

Indice radiografico RASSS (Radiographic AS Spinal Score)

94%

2B

Terms related to these acronyms

1

Indice de salud ASAS-HI (Assessment in SpondyloArthritis international Society- Health Index)

94%

2

Criterio de mejoria ASAS 20 (ASAS 20 improvement criteria)

91%

3

Criterio de mejoria ASAS 40 (ASAS 40 improvement criteria)

100%

4

Criterio de mejoria ASAS 5/6 (ASAS 5/6 improvement criteria)

100%

5

Gran mejoria-ASDAS [ASDAS-MI (major improvement)]

83%

6

Mejoria clinica-ASDAS [ASDAS-CI (clinical improvement)]

72%

7

Remision parcial-ASAS (ASAS partial remission)

70%


Disclosure: V. Navarro-Compán, None; T. Oton-Sanchez, None; E. Loza, None; R. Almodóvar González, None; R. Ariza, None; W. Bautista-Molano, None; R. Burgos-Vargas, None; E. Collantes Estevez, None; E. De Miguel, None; C. M. Gonzalez, None; J. Gratacos-Masmitja, None; S. Ibáñez, None; X. Juanola, None; J. A. Maldonado-Cocco, None; A. Molto, None; J. D. Mulero, None; C. Pacheco-Tena, None; C. Ramos-Remus, None; J. Sanz, None; R. Valle-Oñate, None; P. Zarco, None; H. Marzo-Ortega, None.

To cite this abstract in AMA style:

Navarro-Compán V, Oton-Sanchez T, Loza E, Almodóvar González R, Ariza R, Bautista-Molano W, Burgos-Vargas R, Collantes Estevez E, De Miguel E, Gonzalez CM, Gratacos-Masmitja J, Ibáñez S, Juanola X, Maldonado-Cocco JA, Molto A, Mulero JD, Pacheco-Tena C, Ramos-Remus C, Sanz J, Valle-Oñate R, Zarco P, Marzo-Ortega H. ASAS Consensus on Spanish Nomenclature for Spondyloarthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/asas-consensus-on-spanish-nomenclature-for-spondyloarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/asas-consensus-on-spanish-nomenclature-for-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology